Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith share issue

tada

Nov 13, 2017 11:10PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:34PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:47PM

Re: Zenith share issue

Nextblockbuster

Nov 14, 2017 01:11PM

Re: Zenith share issue

jbuffett62

Nov 15, 2017 11:07AM

Re: Zenith share issue

Nextblockbuster

Nov 15, 2017 12:39PM

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith share issue

in response to

Re: Zenith share issue

Nextblockbuster

posted on Nov 15, 2017 02:41PM

The presentations have said the company will issue 10MM shares shortly not raise $10MM. Hopefully the share issue is done in that $3US neighbourhood. I agree that price would perhaps be good for validation of the science of both companies.